Prefilled Syringes in Biologic Drug Delivery: Innovations in Design and Safety
Ravi Sharma, Shraddha Mahajan · European journal of parenteral & pharmaceutical sciences · 2026
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
European journal of parenteral & pharmaceutical sciences · OpenAlex · article · 2026
Abstract
The rapid growth of biologic therapeutics has driven the need for advanced, patient-centric drug delivery systems that ensure safety, stability, and ease of administration. Prefilled syringes (PFS) have emerged as a preferred delivery format for biologics due to their ability to reduce dosing errors, enhance patient compliance, and streamline healthcare workflows. This review explores the current landscape of PFS in biologic drug delivery, highlighting key innovations in syringe design, material selection, and integration with self-injection devices such as autoinjectors.
Particular attention is given to formulation and stability challenges unique to biologics, including protein aggregation, interactions with syringe components, and cold chain requirements. Advances such as silicone-free syringes, dual-chamber systems, and smart connected devices are discussed in the context of improving usability and safety. Regulatory considerations, including human factors, engineering and post-market surveillance, are examined to underscore the importance of risk mitigation in PFS development.
Finally, the paper discusses market trends, accessibility challenges, and future directions aimed at optimizing the delivery of biologic drugs through prefilled syringe technologies. As biologics continue to dominate therapeutic pipelines, PFS innovations will play a critical role in supporting safe, effective, and patient-friendly drug administration.
Open the resolved locator · 10.37521/ejpps31104
Metadata licence: OpenAlex metadata (CC0)